Skip to content

H2020FP7HORIZON

Instituto de Medicina Molecular Joao Lobo Antunes

Country
PTPortugal
Defence projects
0
Projects, all programmes
69
As coordinator
50
EU contribution (CORDIS)
EUR 34,789,230
Active
2007 to 2025

Projects

69 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
MDR-RADefining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid ArthritisHORIZON2025ParticipantEUR 143,762
LipLAgeExploring lamin-lipid interactions and the loss of nuclear structural integrity as the molecular determinants of human agingH20202021CoordinatorEUR 147,815
GammaDeltaTMECellular and molecular regulators of the pleiotropic activities of gamma delta T cells in the tumor microenvironmentH20202021CoordinatorEUR 159,815
E3glueRBPE3-hijacking molecular glues of RNA binding protein IGF2BP1 in ovarian cancerH20202021CoordinatorEUR 159,815
EvolSpliceKineticsFrom co-transcriptional splicing kinetics to the evolutionary impact of exon and intron definitionH20202020CoordinatorEUR 147,815
INNO4COV-19Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance.H20202020ParticipantEUR 440,000
ClickandTreatCancerLigand Directed NIR-based Theranostic Prodrugs for Prostate CancerH20202020CoordinatorEUR 159,815
SENATORStaff Exchange for Novel applications in 19f magnetic resonance imagingH20202020CoordinatorEUR 234,600
IL7RsignaTHERAntibody-based IL-7R targeted therapiesH20202020CoordinatorEUR 150,000
Cell2CellWhat makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptationH20202019ParticipantEUR 237,720
TRYPTISSUECharacterising Trypanosoma tissue tropism: new perspectives for variant surface glycoproteinsH20202019CoordinatorEUR 159,815
RiboMedRNA in diseaseH20202019CoordinatorEUR 424,750
VeCareSelective retention of VEGF for cancer and retinopathies therapeuticsH20202019CoordinatorEUR 150,000
ADAPT2FLOWAdaptive and maladaptive endothelial cell dynamics during blood flow-driven vascular patterningH20202019CoordinatorEUR 147,815
DevoSignGammaDeltaTracking γδ T cell development and TCRγδ proximal signallingH20202018CoordinatorEUR 160,636
MyoChipBuilding a 3D innervated and irrigated muscle on a chip.H20202018CoordinatorEUR 1,266,861
ACORNNanoparticle-Based Therapeutic Applications and Detection of Carbon Monoxide Releasing MoleculesH20202018CoordinatorEUR 353,750
TRPLigDrugConjTRPV1-targeted ligand-drug conjugates to treat prostate cancerH20202017CoordinatorEUR 160,636
LysoModGenetic and Small Molecule Modifiers of Lysosomal FunctionH20202017CoordinatorEUR 343,800
MUSCLEGUYA novel muscle disorders 3D in vitro system for drug screening and validation.H20202016CoordinatorEUR 150,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.